Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hervé Bastian"'
Autor:
Hervé Bastian, Nadia Lounnas-Mourey, Pierre Heimendinger, Benjamin L. Hsu, Katharina H. Schreeb, Claire Chapman, Emily Culme-Seymour, Gillian F. Atkinson, Diego Cantarovich
Publikováno v:
Translational Medicine Communications, Vol 8, Iss 1, Pp 1-13 (2023)
Abstract Background Gene-modified cell therapy with regulatory T cells (Tregs) is a promising approach to prevent graft rejection and induce immunological tolerance in organ transplantation. We are developing a cell therapy comprising autologous naï
Externí odkaz:
https://doaj.org/article/90b2b72f128048169d0cf93e4def19a3
Autor:
Emma Proics, Marion David, Majid Mojibian, Madeline Speck, Nadia Lounnas-Mourey, Adeline Govehovitch, Wissam Baghdadi, Justine Desnouveaux, Hervé Bastian, Laura Freschi, Geoffrey Privat, Cédric Pouzet, Mauro Grossi, Pierre Heimendinger, Tobias Abel, David Fenard, Megan K. Levings, François Meyer, Céline Dumont
Publikováno v:
Gene Therapy. 30:309-322
A primary goal in transplantation medicine is the induction of a tolerogenic environment for prevention of transplant rejection without the need for long-term pharmacological immunosuppression. Generation of alloantigen-specific regulatory T cells (T
Publikováno v:
International immunopharmacology. 9(5)
IL-10 producing regulatory type 1 (Tr1) cells represents a subpopulation of CD4(+) regulatory cells able to prevent in vitro bystander T-cell proliferation and to cure ongoing chronic colitis in mice. In order to assess the efficacy and tolerance of
Autor:
Amélie Mantello-Moreau, Julie Quentin, Anne-Laure Mausset-Bonnefont, Papa Babacar Fall, Arnaud Foussat, Pascale Louis-Plence, Irène Marchetti, Christian Jorgensen, Sandrine Rouquier, Mathilde Boucard-Jourdin, Hervé Bastian, Hélène Asnagli, Nathalie Belmonte, Delphine Martire
Publikováno v:
Arthritis Research & Therapy
Arthritis Research and Therapy
Arthritis Research and Therapy, BioMed Central, 2014, 16 (3), ⟨10.1186/ar4567⟩
Arthritis Research and Therapy
Arthritis Research and Therapy, BioMed Central, 2014, 16 (3), ⟨10.1186/ar4567⟩
International audience; Introduction: Regulatory T (Treg) cells play a crucial role in preventing autoimmune diseases and are an idealtarget for the development of therapies designed to suppress inflammation in an antigen-specific manner.Type 1 regul
Autor:
Virginie Neveu, Matthieu Allez, Laurent Beaugerie, Patricia Morel–Mandrino, Nathalie Belmonte, Jean-Frederic Colombel, Hervé Bastian, Maria Nachury, Miguel Forte, Michel Ticchioni, Valérie Brun, Agnès Duchange, Arnaud Foussat, Xavier Hébuterne, Yoram Bouhnik, Pierre Desreumaux, Nathalie Clerget–Chossat
Publikováno v:
Gastroenterology
Gastroenterology, WB Saunders, 2012, 143 (5), pp.1207-1217.e2. ⟨10.1053/j.gastro.2012.07.116⟩
Gastroenterology, 2012, 143 (5), pp.1207-1217.e2. ⟨10.1053/j.gastro.2012.07.116⟩
Gastroenterology, WB Saunders, 2012, 143 (5), pp.1207-1217.e2. ⟨10.1053/j.gastro.2012.07.116⟩
Gastroenterology, 2012, 143 (5), pp.1207-1217.e2. ⟨10.1053/j.gastro.2012.07.116⟩
Background & Aims New therapeutic strategies are needed for patients with refractory Crohn's disease (CD). We evaluated data from the Crohn's And Treg Cells Study (CATS1) to determine the safety and efficacy of antigen-specific T-regulatory (Treg) ce